Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3349 | 1249 | 38.0 | 73% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
449 | 23681 | SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
16912 | 564 | CARRIER ERYTHROCYTES//NANOERYTHROSOMES//HYPOTONIC DIALYSIS |
23153 | 301 | CAROLINA CANC NANOTECHNOL EXCELLENCE//ARTIFICIAL ANTIGEN PRESENTING CELL//SLOAN KETTERING CANC |
25488 | 232 | VASCULAR IMMUNOTARGETING//TARGETED THER EUT TRANSLAT NANOMED//TRANSLAT TARGETED THER EUT NANOMED |
29491 | 152 | PLATELET SUBSTITUTE//ORG EUROPEAN STUDIES//TWINSSHINJUKU KU |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | Author keyword | 26 | 68% | 2% | 23 |
2 | VASCULAR IMMUNOTARGETING | Author keyword | 20 | 100% | 1% | 9 |
3 | NANOERYTHROSOMES | Author keyword | 18 | 89% | 1% | 8 |
4 | TRANSLAT TARGETED THER EUT NANOMED | Address | 17 | 100% | 1% | 8 |
5 | HYPOTONIC DIALYSIS | Author keyword | 15 | 82% | 1% | 9 |
6 | TARGETED THER EUT TRANSLAT NANOMED | Address | 15 | 82% | 1% | 9 |
7 | IFEM | Address | 14 | 100% | 1% | 7 |
8 | CAROLINA CANC NANOTECHNOL EXCELLENCE | Address | 12 | 41% | 2% | 22 |
9 | ARTIFICIAL ANTIGEN PRESENTING CELL | Author keyword | 9 | 64% | 1% | 9 |
10 | TARGETED THER EUT PROGRAM | Address | 8 | 70% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | 119 | 84% | 5% | 66 |
2 | LOADED ERYTHROCYTES | 61 | 95% | 2% | 20 |
3 | POLYMER NANOCARRIERS | 41 | 81% | 2% | 25 |
4 | ALLEVIATES OXIDATIVE STRESS | 21 | 90% | 1% | 9 |
5 | SEVERELY THROMBOCYTOPENIC RABBITS | 20 | 100% | 1% | 9 |
6 | PROPHYLACTIC FIBRINOLYSIS | 15 | 63% | 1% | 15 |
7 | ENZYME LOADED ERYTHROCYTES | 14 | 100% | 1% | 7 |
8 | DIALYSIS ENCAPSULATION | 11 | 100% | 0% | 6 |
9 | CLASS I PEPTIDE COMPLEXES | 11 | 78% | 1% | 7 |
10 | ICAM 1 TARGETED NANOCARRIERS | 11 | 78% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications | 2015 | 2 | 97 | 26% |
Drug, enzyme and peptide delivery using erythrocytes as carriers | 2004 | 67 | 122 | 80% |
Carrier erythrocytes: recent advances, present status, current trends and future horizons | 2014 | 4 | 78 | 90% |
Drug delivery by red blood cells: vascular carriers designed by mother nature | 2010 | 63 | 270 | 45% |
The importance of nanoparticle shape in cancer drug delivery | 2015 | 2 | 117 | 20% |
Linking form to function: Biophysical aspects of artificial antigen presenting cell design | 2015 | 2 | 160 | 19% |
Applications of carrier erythrocytes in delivery of biopharmaceuticals | 2007 | 58 | 118 | 65% |
Carrier erythrocytes: An overview | 2003 | 67 | 31 | 84% |
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics | 2011 | 73 | 57 | 32% |
Bio-inspired, bioengineered and biomimetic drug delivery carriers | 2011 | 181 | 155 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSLAT TARGETED THER EUT NANOMED | 17 | 100% | 0.6% | 8 |
2 | TARGETED THER EUT TRANSLAT NANOMED | 15 | 82% | 0.7% | 9 |
3 | IFEM | 14 | 100% | 0.6% | 7 |
4 | CAROLINA CANC NANOTECHNOL EXCELLENCE | 12 | 41% | 1.8% | 22 |
5 | TARGETED THER EUT PROGRAM | 8 | 70% | 0.6% | 7 |
6 | MED BIOL SECT ENDOTHELIAL BIOMED VASC DRUG | 6 | 80% | 0.3% | 4 |
7 | ORG EUROPEAN STUDIES | 6 | 80% | 0.3% | 4 |
8 | TWINSSHINJUKU KU | 6 | 58% | 0.6% | 7 |
9 | SLOAN KETTERING CANC | 6 | 23% | 1.8% | 23 |
10 | LIFE SCI MED BIOSCI | 3 | 10% | 2.5% | 31 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016313 | LAYER BY LAYER//LAYER BY LAYER ASSEMBLY//POLYELECTROLYTE MULTILAYERS |
2 | 0.0000013668 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
3 | 0.0000013485 | L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE |
4 | 0.0000010902 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
5 | 0.0000009913 | ELECTROCHEMOTHERAPY//ELECTROPERMEABILIZATION//ELECTROPORATION |
6 | 0.0000009861 | SINGLE MOLECULE FORCE SPECTROSCOPY//FORCE SPECTROSCOPY//MECHANICAL UNFOLDING |
7 | 0.0000009489 | E SELECTIN//SELECTIN//ICAM 1 |
8 | 0.0000008662 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |
9 | 0.0000008395 | NANOTOXICOLOGY//PROTEIN CORONA//NANOTOXICITY |
10 | 0.0000007869 | ADJUVANT//M CELLS//M CELL |